Clinical Trial Update: STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity [Phase 3]

View source ↗

Summary

Phase 3 trial update for semaglutide in overweight or obesity completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolism and Nutrition Disorder
• Overweight or Obesity

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Metabolism and Nutrition Disorder, Overweight or Obesity | Phase 3 | Status: COMPLETED | Results posted: 2021-08-11